Articaine ophthalmic - American Genomics
Alternative Names: AG-920Latest Information Update: 26 Aug 2022
At a glance
- Originator American Genomics
- Class Amides; Amines; Esters; Local anaesthetics; Small molecules; Thiophenes
- Mechanism of Action Central nervous system modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Anaesthesia
Most Recent Events
- 16 Aug 2022 Phase-III clinical trials in Anaesthesia (In volunteers) in USA (Ophthalmic) (NCT05501860)
- 10 May 2022 American Genomics completes a phase-III clinical trials in Anaesthesia (In volunteers) in USA (Ophthalmic) (NCT04829344)
- 30 Mar 2021 Phase-III clinical trials in Anaesthesia (In volunteers) in USA (Ophthalmic) (NCT04829344)